IMMUNOCORE HLDGS ADS/1 (6YG) — Defensive Interval Ratio

Latest as of December 2025: 696 days

IMMUNOCORE HLDGS ADS/1 (6YG) has a Defensive Interval Ratio of 696 days as of December 2025. Defensive assets of €470.42 Million (cash €-, short-term investments €396.44 Million, receivables €73.98 Million) cover 696 days of daily cash needs of €675.88K/day. Check IMMUNOCORE HLDGS ADS/1 tangible net worth ratio to evaluate the tangible quality of the company's equity base.

Defensive Interval Ratio

696 days
Days of operational coverage

Defensive Assets

€470.42 Million
Cash + ST Investments + Receivables

Daily Cash Need

€675.88K
Current Liabilities ÷ 365

Current Liabilities

€246.70 Million
EUR

IMMUNOCORE HLDGS ADS/1 Defensive Interval Ratio (2022–2025)

This chart shows how IMMUNOCORE HLDGS ADS/1's Defensive Interval Ratio has evolved across 4 annual periods from 2022 to 2025. As of December 2025, the ratio stands at 696 days, meaning defensive assets of €470.42 Million can fund 696 days of operations without new revenue. Also explore 6YG year-over-year net asset growth to track the company's year-over-year net asset growth rate.

Annual Defensive Interval Ratio for IMMUNOCORE HLDGS ADS/1 (2022–2025)

The table below presents the year-by-year Defensive Interval Ratio for IMMUNOCORE HLDGS ADS/1 from 2022 to 2025, covering 4 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see 6YG stock market capitalisation.

Year DIR (days) Defensive Assets (EUR) Daily Cash Need Cash ST Investments Change (days)
2025 696 days €470.42 Million €675.88K/day €- €396.44 Million ▼ -40 days
2024 736 days €427.65 Million €581.32K/day €- €364.64 Million ▲ +599 days
2023 137 days €52.09 Million €380.88K/day €- €0.00 ▲ +15 days
2022 122 days €33.58 Million €276.26K/day €- €-
DIR = (Cash + Short-term Investments + Net Receivables) / (Daily Cash Expenses)